Posts Tagged ‘Canadian drug importation’
Florida’s final submission: November 2023 documents for its Canadian drug importation program
The state of Florida provided these FOIA-responsive documents to PSM for the state’s final and ultimately approved application to establish a Canadian drug importation program.
[...]Colorado updates drug importation proposal, cuts list of meds by 88, adds Ozempic
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
[...]Florida’s October 20, 2023 Section 804 Proposal for the Importation of Prescription Drugs from Canada
Florida’s October 20, 2023 SIP application is the second to last application before FDA approval. The final application was filed on November 16, 2023.
[...]PSM files a supplement to citizen petition opposing Florida’s importation proposal
In September, the Partnership for Safe Medicines and others filed a supplement to our 2021 Citizen’s Petition asking the U.S. Department of Health and Human Services not to authorize Florida’s Canadian Drug Importation Plan.
[...]Decision on Florida’s importation program delayed
A delay in Florida’s response to FDA questions means the agency’s decision won’t be by October 31 after all.
[...]Colorado’s Canadian drug importation plan won’t be safe and also won’t save money
Colorado submitted its application to the FDA to import medicine from Canada on December 5. Like other Canadian importation plans, this one isn’t safe and it’s unlikely to save money.
[...]Why has Florida paid 27 million dollars for an empty warehouse?
When Governor Ron DeSantis signed HB19 into law in June 2019, he said that Florida was leading “the way toward affordable prescription drugs,” but over the past three years not a single person has received even one pill imported from Canada, and the state has spent millions.
[...]Drug Importation Is Not The Solution Americans Need
While working to find a way to provide relief to patients at the pharmacy counter, American politicians again look to the idea of drug importation as a possible solution. Looking at all the evidence, the Partnership for Safe Medicines believes such plans will not only make no difference in reducing patient out-of-pocket costs, but will…
[...]Connecticut Bioscience Growth Council ED explains why drug importation is “unworkable.”
In this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
[...]“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]